14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AGRX
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Agile Therapeutics stock price fell more than -6.74% Thursday closing at $0.317
(Updated on Jun 20, 2024)

Sell candidate since Jun 12, 2024 Loss -11.48% PDF

The Agile Therapeutics stock price fell by -6.74% on the last day (Thursday, 20th Jun 2024) from $0.340 to $0.317. During the last trading day the stock fluctuated 7.26% from a day low at $0.317 to a day high of $0.340. The price has fallen in 5 of the last 10 days and is down by -16.58% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -20 thousand shares and in total, 1 thousand shares were bought and sold for approximately $460.28 .

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -7.73% during the next 3 months and, with a 90% probability hold a price between $0.219 and $0.392 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AGRX Signals & Forecast

There are few to no technical positive signals at the moment. The Agile Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.344 and $0.377. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, April 30, 2024, and so far it has fallen -28.76%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Agile Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.290 and $0.273. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Agile Therapeutics finds support just below today's level at $0.290. If this is broken, then the next support from accumulated volume will be at $0.273 and $0.270.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0230 between high and low, or 7.26%. For the last week the stock has had daily average volatility of 5.79%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AGRX) For The Upcoming Trading Day Of Friday 21st

For the upcoming trading day on Friday, 21st we expect Agile Therapeutics to open at $0.325, and during the day (based on 14 day Average True Range), to move between $0.295 and $0.339, which gives a possible trading interval of +/-$0.0221 (+/-6.96%) up or down from last closing price. If Agile Therapeutics takes out the full calculated possible swing range there will be an estimated 13.91% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.334 (5.36%) than the support at $0.290 (8.52%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Agile Therapeutics stock A Buy?

Agile Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.101 Sell Candidate Unchanged

Predicted Opening Price for Agile Therapeutics of Friday, June 21, 2024

Fair opening price June 21, 2024 Current price
$0.325 ( 2.42%) $0.317

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AGRX

Fibonacci Support & Resistance Levels

Level Price
R3 0.348 9.67%
R2 0.339 6.90%
R1 0.333 5.19%
Price 0.317
S1 0.316 -0.353%
S2 0.310 -2.07%
S3 0.302 -4.84%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.394 24.29%
R2 0.370 16.72%
R1 0.334 5.36%
Price 0.317
S1 0.290 -8.52%
S2 0.273 -14.01%
S3 0.270 -14.83%

FAQ

What is the symbol for Agile Therapeutics Stock and on which exchange is it traded?
The symbol for Agile Therapeutics is AGRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Agile Therapeutics Stock?
Agile Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Agile Therapeutics Stock?
Agile Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Agile Therapeutics Stock.

What's the current price of Agile Therapeutics Stock?
As of the end of day on the Jun 20, 2024, the price of an Agile Therapeutics (AGRX) share was $0.317.

What is the 52-week high and low for Agile Therapeutics Stock?
The 52-week high for Agile Therapeutics Stock is $3.40 and the 52-week low is $0.200.

What is the market capitalization of Agile Therapeutics Stock?
As of the Jun 20, 2024, the market capitalization of Agile Therapeutics is 2.33M.

When is the next earnings date for Agile Therapeutics?
The upcoming earnings date for Agile Therapeutics is Aug 07, 2024.
Click to get the best stock tips daily for free!

About Agile Therapeutics

Agile Therapeutics Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to h... AGRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT